- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 908348, 7 pages
Anti-Inflammatory and Antiapoptotic Responses to Infection: A Common Denominator of Human and Bovine Macrophages Infected with Mycobacterium avium Subsp. paratuberculosis
Department of Animal Health, Basque Institute for Agricultural Research and Development, NEIKER-Tecnalia, Technological Park of Bizkaia, 48160 Derio, Bizkaia, Spain
Received 27 September 2012; Accepted 26 December 2012
Academic Editor: Reinaldo B. Oriá
Copyright © 2013 Naiara Abendaño et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Mycobacterium avium subsp. paratuberculosis (Map) is the causative agent of a chronic intestinal inflammation in ruminants named Johne's disease or paratuberculosis and a possible etiopathological agent of human Crohn's disease (CD). Analysis of macrophage transcriptomes in response to Map infection is expected to provide key missing information in the understanding of the role of this pathogen in establishing an inappropriate and persistent infection in a susceptible host and of the molecular mechanisms that might underlie the early phases of CD. In this paper we summarize transcriptomic studies of human and bovine peripheral blood mononuclear cells (PBMC), monocyte-derived macrophages (MDMs), and macrophages-like cell lines in vitro infected with Map. Most studies included in this paper consistently reported common gene expression signatures of bovine and human macrophages in response to Map such as enhanced expression of the anti-inflammatory cytokines IL-10 and IL-6, which promote bacterial survival. Overexpression of IL-10 could be responsible for the Map-associated reduction in the expression of the proapoptotic TNF-α gene observed in bovine and human macrophages.
1. Association of Mycobacterium avium Subsp. paratuberculosis (Map) with Chronic Inflammatory Bowell Diseases of Cattle and Humans
Mycobacterium avium subsp. paratuberculosis (Map) is the causal agent of Johne's disease or paratuberculosis, a chronic inflammatory bowel disease of domesticated ruminants and wildlife species worldwide. Johne's disease causes major economic losses to the global dairy industry due to reduced milk production, lower weight gains, infertility, premature culling, and increased cow replacement costs . Map has a worldwide distribution and is of considerable concern in cattle, sheep, goats, and farmed red deer. Although it is still controversial, Map has been implicated as a causal or exacerbating agent in human Crohns's disease (CD), a chronic inflammatory bowel disease characterized by transmural inflammation and granuloma formation [2–4]. Evidences that Map may be associated to CD in humans include similarity between the clinical signs of CD in humans and those found in animals with paratuberculosis; detection of Map in feces, intestinal tissues, breast milk, macrophages, and peripheral blood of patients with CD; association between Map DNA in blood and cellular and humoral immune responses in CD; and anti-Map antibiotic therapy resulting in reduction of bacteremia and remission or substantial improvement in disease condition in many patients [5–10]. In addition, meta-analysis and epidemiological studies have confirmed an association of Map with CD [11, 12].
Map may enter the food chain from a variety of sources. The organism, shed from infected animals, may contaminate pastures and potable water, where it is resistant to standard purification with chlorine . Because Map can survive pasteurization conditions, dairy products such as milk and cheese have been proposed as possible sources of exposure of humans to Map . Recently, we have demonstrated that Map can be detected and cultured from diaphragm muscle of Map-infected cattle destined for human consumption and suggested a possible risk of exposure of humans to Map via contaminated meat . After oral ingestion, Map invades the intestinal wall preferably through epithelial cells or M cells present in the follicle-associated epithelium covering the continuous Peyer's patches in the distal ileum [16–18]. Although the mechanism of entry in the mucosa is important in establishing Map infection, most of the bacterial components involved in the interaction with the intestinal epithelium are still unknown. It has been recently demonstrated that Map3464 gene encodes an NADH-flavin oxidoreductase involved in invasion of bovine epithelial cells through the activation of host cell Cdc42 . After translocation of Map across the intestinal epithelium, Map is subsequently phagocytised by macrophages in the intestinal lamina propria and submucosa. Upon phagocytosis of Map by naive macrophages, there is both intracellular replication of Map and bacterial killing by the host, which reflects an initial T-helper 1 (Th-1) or proinflammatory immune response [20–24]. Bacterial killing is due to a rapid phagosome acidification response by the host that enables phagosome-lysosome fusion and presentation of antigens to T cells via MHC to occur in some infected cells. However, since many phagosomes containing Map fail to acquire significant amounts of lysosomal-associated membrane protein (LAMP-1) and to fuse with lysosomes, this can allow Map to survive and proliferate inside macrophages. An active role for Map in preventing phagosome-lysosome fusion is supported by the observation that live bacteria are able to persist within phagosomes, while phagosome maturation is not interrupted following the uptake of killed Map [25, 26]. In addition, recent studies have suggested that Map alters the ability of infected macrophages to react to extracellular signals from T cells, particularly through the CD154-CD40 system . This leads to an enhanced IL-10 and TGF- expression in Map-infected macrophages, which favor bacterial survival by suppression of Th-1 responses and IFN- in T cells [28–31]. In cattle, clinical signs of infection and bacterial shedding are usually not evident until 2–5 years post-infection (p.i.) . During the subclinical phase of the infection, Map persists and slowly proliferates within macrophages of the gut without the innate system being able to clear the infection.
2. Anti-Inflammatory, Antiapoptotic, and Anti-Invasive Responses Induced in Bovine Macrophages Infected with Mycobacterium avium Subsp. paratuberculosis
Several in vitro studies have investigated gene expression profiles induced by Map on bovine macrophages obtained from uninfected cattle and on a bovine macrophage cell line (Table 1). Compared to uninfected cultures, in vitro challenges of monocytes-derived macrophages (MDMs) from healthy cows with live Map resulted in enhanced production of the anti-inflammatory cytokine interleukin-10 (IL-10) at 6, 24, and 72 h p.i. that antagonizes the proinflammatory immune response by downregulating the production of interleukin-12 (IL-12), tumor necrosis factor- (TNF-), and interferon- (IFN-) as estimated by qRT-PCR . Similarly, other authors also observed a downregulatory trend in TNF- mRNA expression from 16 h to 96 h p.i. and upregulation of IL-10 mRNA levels that peak from 48 h to 96 h p.i. . Using microarray technology, three cytokines including transforming growth factor- (TGF-), interleukin-6 (IL-6), and macrophage inflammatory protein-1 (MIP-1) had greater expression in Map-infected MDM at 16 h p.i. when compared with inactivated control macrophages . The matrix metalloproteinase (MMP-12) and the thrombospondin-1, both involved in cell migration and tissue destruction, were also significantly upregulated. In contrast, the TNF- receptor and the major histocompatibility complex (MHC) class II DQ- had lower expression in Map-infected macrophages. Decreased expression of the cell surface MHC class I and class II molecules was previously documented in macrophages phagocytising Map organisms indicating a reduced capacity to present antigens to T lymphocytes . Consistently with these results, Murphy et al. also detected high levels of the anti-inflammatory cytokines TGF- and IL-6 in MDM infected with Map at 24 h p.i. . In another study, significantly downregulation in expression of the proinflammatory cytokine IL-1 and of the metalloproteinases MMP-1, MMP-23, and MMP-9 involved in tissue destruction was observed in Map-stimulated PBMC when compared with control cells . Using cDNA microarrays focused on expressed sequences from a bovine total leukocyte library (BOLT5) and 10 distinct Map strains to measure total transcriptomic alterations in Map-infected MDM, a total of 78 annotated bovine genes were found to be differentially expressed at 6 h p.i., relative to uninfected cells . Within the group of differentially expressed genes significant downregulation of two proapoptotic genes, BCL2 antagonist of cell death (BAD) and TNF receptor (TNFR), was observed in Map-infected MDM cells relative to uninfected cells. Upregulation of the apoptotic inhibitor BCL2A1 and of the proinflammatory cytokines IL-1, IL-1, and IL-8 relative to uninfected control cells was also observed. By using a pan-genomic analysis of bovine MDM gene expression in response to in vitro infection with Map, Machugh et al. revealed that many of the highly upregulated genes at 2 h p.i. had proinflammatory related functions, particularly IL-1, IL-1, TNF, IL-6, chemokine ligand 2 gene (C-X-C motif; CXCL2), and the chemokine ligand 20 gene (C-C motif; CCL20) . At 6 h p.i. immune-related genes were among the differentially expressed genes showing the highest relative increase in expression; however, the fold-change induction of these genes was not as high as those detected as 2 h p.i. Upregulated genes at 6 h p.i. included IL-1, TNF, CXCL2, CCL4, CCL5, CCL20, CD40, and the complement factor B gene (CFB). Of the differentially expressed gene identified 24 h p.i. that had a known immune function were the serum amyloid A3 genes (SAA3), C-type lectin domain family 4 member E (CLEC4E), C-type lectin domain family 2 member D (CLEC2D), CD40, and CFB. Overall, several pro- and antiapoptotic genes were upregulated at 2 h and 6 h p.i. suggesting that this process is highly regulated. Pro- and antiapoptotic genes upregulated included TNF (proapoptotic), caspase 1, 4, 6, and 8 genes (CASP-1, CASP-4, CASP-6, and CASP-8; all proapoptotic), the baculoviral IAP repeat containing 3 gene (BIRC-3; antiapoptotic), and the FADD-like apoptosis regulator gene (CFLAR; pro- and antiapoptotic).
We recently examined whether Map isolates with differential abilities to grow within a bovine macrophage cell line (BoMac) induced a characteristic early immune-inflammatory response . Our results showed significant differences in the expression of several cytokines (IL-6, TGF-1, TNF-2, IFN-, and IL-1), proteins related to apoptosis (BCL2-1), or tissue destruction (MMP3-1) after the infection of BoMac cells with a bovine or an ovine isolate of Map. The bovine isolate that grew within BoMac cells was a good inducer of the apoptotic inhibitor BCL2-1 at 4 or 14 h p.i. which might cause lower levels of apoptosis than in BoMac cells infected with the ovine isolate. In addition, infection of BoMac cells with the bovine isolate resulted in a significant upregulation of the anti-inflammatory cytokines IL-6 and TGF-1 at 24 h p.i., when compared with cells infected with the ovine isolate. Although we did not observe significant differences in IL-10 or TNF-2 gene expression in BoMac cells infected with the bovine or the ovine isolates at any of the time points, the bovine isolate did induce more IL-10 at 14 and 24 h p.i and less TNF-2 at 4 and 14 h p.i. than did the ovine isolate. These results suggest that lower TNF-2 production and an induction of IL-10 are associated with the growth within bovine macrophages of virulent isolates of Map. We also observed that cells stimulated with the bovine isolate exhibited lower levels of the metalloproteinase MMP3-1 involved in tissue destruction at 4 h and 24 h p.i. relative to cells stimulated with the ovine isolate. Differences in induction of the metalloproteinase inhibitor TIMP-1 were not statistically significant at any of the time points studied but the bovine isolate did induce more TIMP-1 at 4 h p.i. than did the ovine isolate. The ovine isolate was significantly attenuated in growth in BoMac cells and this decrease in survival within the infected cells correlated with a reduced anti-inflammatory response in the infected cells and with a significantly upregulated proinflammatory immune response generally associated with elimination of Map and protection. In particular, the expression of the proinflammatory cytokine IL-1 was highly upregulated in cells infected with the ovine isolate at 14 and 24 h p.i. and downregulated in BoMac cells infected with the bovine isolate at 24 h p.i. Because a strong correlation between the intracellular multiplication of the tested isolates and patterns of production of IL-6, TGF-, MMPL-3, BCL2-1, and IL-1 was observed, the levels of expression of these specific proteins might be used to discriminate between isolates with differential virulence in the BoMac cellular model.
All together, the results of the transcriptomic studies in bovine macrophages included in this paper suggested that Map might stimulated an initial proinflammatory immune response mediated by IL-1 that is followed by an enhanced anti-inflammatory response mediated by IL-6, IL-10, and TGF-. In addition, downregulation of the proapoptotic gene TNF- was consistently observed in different studies. Stimulation of anti-inflammatory and antiapoptotic responses might allow Map to successfully persist in bovine macrophages during the persistent, subclinical phase of the infection.
3. Immune-Inflammatory Responses Induced in Human Macrophages Infected with Map
Despite the possible role of Map in CD, there is not much known about the interaction of Map with the human innate immune system (Table 2). A transformed human monocytic cell line (THP1) stimulated with Map has shown to differentially respond to infections with well-characterized clinical isolates of Map when compared with unstimulated cells. When human THP1 cells were stimulated with bovine or human isolates of Map several genes associated with apoptosis and cytokine signalling (LRDD, PDCD-8, IL-12, IL-18, IL-23, and TNF) were significantly downregulated . Data from this study suggested that the human macrophage responses to Map isolates from cattle or human sources, regardless of genotype, follow a common theme of antiapoptotic and anti-inflammatory responses within the host cells, an attribute likely associated with successful infection and persistence.
The response of macrophages from CD patients to live Map has been recently addressed. Following in vitro exposure to Map, PBMC from CD patients secreted significant more amounts of TNF-, IL-6, and IL-10 when compared to the levels released by PBMC from healthy volunteers . In contrast, the IFN- response to Map was significantly elevated in PBMC isolated from healthy volunteers compared to PBMC derived from CD patients. In another study, human MDMs obtained from CD patients and controls were infected with Map, Mycobacterium avium subsp. avium (Mav), and other live intestinal bacteria such as Escherichia coli or Enterococcus faecalis, and cytokine levels were evaluated at different time points . The results of this study indicated that macrophages from CD patients showed impaired TNF- secretion in response to bacterial challenge but augmented IL-23 secretion as compared to macrophages from healthy individuals. It is plausible that the MAP-dependent IL-23 secretion enhancement occurred as consequence of phagocytosis, because the high IL-23 concentrations obtained at 3 h p.i. were not observed at 3 d and 7 d p.i. Differences in cytokine expression after bacterial challenge where not Map specific, as other bacteria (E. coli and Mav) showed similar effects.
Although most of the studies presented in this paper used PBMC or MDM cells in vitro stimulated with Map, we should indicate that recently Olsen et al.  isolated intestinal T cells from intestinal biopsies of CD patients to investigate cellular immune responses to Map. Interestingly, they observed that CD patients had a high frequency of Map reactive T cells and also a higher frequency of response to Map compared to other bacterial antigens. After stimulation with Map, intestinal T cells secreted the proinflammatory cytokines IFN- and IL-17, and, therefore, a role for Map in the excessive inflammation seen in CD cannot be excluded.
Despite development of cell-mediated immune responses shortly after infection, Map has the capacity to survive and grow in macrophages from human and cattle hosts. Gene expression studies included in this paper allow us to conclude that the inhibition of apoptosis and enhanced expression of inhibitors of macrophage activation could contribute to the early survival and immune escape of Map. Common gene expression signatures of bovine and human macrophages in response to Map such as enhanced expression of the anti-inflammatory cytokines IL-10 and IL-6, which promote bacterial survival, have been consistently observed. Overexpression of IL-10 could be responsible for the Map-associated reduction in the expression of the proapoptotic TNF- gene observed in many studies. Differential effects on macrophage gene regulation between studies might be caused by the different in vitro models, multiplicities of infection, time p.i., and/or microarray platforms used. Although this paper does not suggest a casual effect for Map, it does compile the findings that Map is able to alter the normal host immune response against a pathogen in susceptible humans and cattle and contribute to the pathogenesis of Crohn's and Johne's diseases.
Financial support for this work was provided by Grants from the Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA) and by European Funds for Regional Development (FEDER) (FAU2008-00018-C02 and RTA2011-06049). Dr. M. Alonso-Hearn's tenure is partly covered by the INIA tenure track program for the incorporation of Ph. D. graduates into research institutions. N. Abendaño has a fellowship from the Department of Agriculture of the Basque Government. We thank Dr. Luiz Bermudez for helpful discussions. We are grateful to Kyle Hearn for the careful editing of the paper.
- S. L. Ott, S. J. Wells, and B. A. Wagner, “Herd-level economic losses associated with Johne's disease on US dairy operations,” Preventive Veterinary Medicine, vol. 40, no. 3-4, pp. 179–192, 1999.
- W. Chamberlin, D. Y. Graham, K. Hulten et al., “Review article: Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease,” Alimentary Pharmacology and Therapeutics, vol. 15, no. 3, pp. 337–346, 2001.
- R. Juste, “Slow infection control by vaccination,” Veterinary Immunology and Immunopathology, vol. 148, pp. 190–196, 2012.
- R. Juste, “Current strategies for eradication of paratuberculosis and issues in public health,” Veterinary Immunology and Immunopathology, vol. 148, pp. 16–22, 2012.
- S. A. Naser, I. Shafran, D. Schwartz, F. El-Zaatari, and J. Biggerstaff, “In situ identification of mycobacteria in Crohn's disease patient tissue using confocal scanning laser microscopy,” Molecular and Cellular Probes, vol. 16, no. 1, pp. 41–48, 2002.
- S. A. Naser, G. Ghobrial, C. Romero, and J. F. Valentine, “Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease,” The Lancet, vol. 364, no. 9439, pp. 1039–1044, 2004.
- R. B. Gearry, J. M. Aitken, R. L. Roberts, S. Ismail, J. Keenan, and M. L. Barclay, “Gastrointestinal: Mycobacterium avium paratuberculosis and Crohn's disease,” Journal of Gastroenterology and Hepatology, vol. 20, no. 12, p. 1943, 2005.
- A. M. Scanu, T. J. Bull, S. Cannas et al., “Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicities,” Journal of Clinical Microbiology, vol. 45, no. 12, pp. 3883–3890, 2007.
- R. A. Juste, N. Elguezabal, A. Pavón et al., “Association between Mycobacterium avium subsp. paratuberculosis DNA in blood and cellular and humoral immune response in inflammatory bowel disease patients and controls,” International Journal of Infectious Diseases, vol. 13, no. 2, pp. 247–254, 2009.
- R. A. Juste, N. Elguezabal, J. M. Garrido, et al., “On the prevalence of M. avium subspecies paratuberculosis DNA in the blood of healthy individuals and patients with inflammatory bowel disease,” PLoS ONE, vol. 3, article e2537, 2008.
- I. Abubakar, D. Myhill, S. H. Aliyu, and P. R. Hunter, “Detection of Mycobacterium avium subspecies paratubercubsis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis,” Inflammatory Bowel Diseases, vol. 14, no. 3, pp. 401–410, 2008.
- M. Feller, K. Huwiler, R. Stephan et al., “Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis,” Lancet Infectious Diseases, vol. 7, no. 9, pp. 607–613, 2007.
- E. S. Pierce, “Possible transmission of Mycobacterium avium subspecies paratuberculosis through potable water: lessons from an urban cluster of Crohn's disease,” Gut Pathogens, vol. 23, p. 17, 2009.
- R. J. Chiodini and J. Hermon-Taylor, “The thermal resistance of Mycobacterium paratuberculosis in raw milk under conditions simulating pasteurization,” Journal of Veterinary Diagnostic Investigation, vol. 37, pp. 1645–1648, 1993.
- M. Alonso-Hearn, E. Molina, M. Geijo et al., “Isolation of Mycobacterium avium subsp. paratuberculosis from muscle tissue of naturally infected cattle,” Foodborne Pathogens and Disease, vol. 6, no. 4, pp. 513–518, 2009.
- E. Momotani, D. L. Whipple, A. B. Thiermann, and N. F. Cheville, “Role of M cells and macrophages in the entrance of Mycobacterium paratuberculosis into domes of ileal Peyer's patches in calves,” Veterinary Pathology, vol. 25, no. 2, pp. 131–137, 1988.
- N. B. Harris and R. G. Barletta, “Mycobacterium avium subsp. paratuberculosis in veterinary medicine,” Clinical Microbiology Reviews, vol. 14, no. 3, pp. 489–512, 2001.
- L. E. Bermudez, M. Petrofsky, S. Sommer, and R. G. Barletta, “Peyer's patch-deficient mice demonstrate that Mycobacterium avium subsp. paratuberculosis translocates across the mucosal barrier via both M cells and enterocytes but has inefficient dissemination,” Infection and Immunity, vol. 78, no. 8, pp. 3570–3577, 2010.
- M. Alonso-Hearn, D. Patel, L. Danelishvili, L. Meunier-Goddik, and L. E. Bermudez, “The Mycobacterium avium subsp. paratuberculosis MAP3464 gene encodes an oxidoreductase involved in invasion of bovine epithelial cells through the activation of host cell Cdc42,” Infection and Immunity, vol. 76, no. 1, pp. 170–178, 2008.
- S. Alonso, K. Pethe, D. G. Russell, and G. E. Purdy, “Lysosomal killing of Mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 14, pp. 6031–6036, 2007.
- M. T. Rowe and I. R. Grant, “Mycobacterium avium ssp. paratuberculosis and its potential survival tactics,” Letters in Applied Microbiology, vol. 42, no. 4, pp. 305–311, 2006.
- S. R. Woo, J. A. Heintz, R. Albrecht, R. G. Barletta, and C. J. Czuprynski, “Life and death in bovine monocytes: the fate of Mycobacterium avium subsp. paratuberculosis,” Microbial Pathogenesis, vol. 43, no. 2, pp. 106–113, 2007.
- B. Y. Zhao, C. J. Czuprynski, and M. T. Collins, “Intracellular fate of Mycobacterium avium subspecies paratuberculosis in monocytes from normal and infected, interferon-responsive cows as determined by a radiometric method,” Canadian Journal of Veterinary Research, vol. 63, no. 1, pp. 56–61, 1999.
- M. P. Kuehnel, R. Goethe, A. Habermann et al., “Characterization of the intracellular survival of Mycobacterium avium ssp. paratuberculosis: phagosomal pH and fusogenicity in J774 macrophages compared with other mycobacteria,” Cellular Microbiology, vol. 3, no. 8, pp. 551–566, 2001.
- J. P. Bannantine and J. R. Stabel, “Killing of Mycobacterium avium subspecies paratuberculosis within macrophages,” BMC Microbiology, vol. 2, no. 1, p. 2, 2002.
- J. Hostetter, E. Steadham, J. Haynes, T. Bailey, and N. Cheville, “Phagosomal maturation and intracellular survival of Mycobacterium avium subspecies paratuberculosis in J774 cells,” Comparative Immunology, Microbiology and Infectious Diseases, vol. 26, no. 4, pp. 269–283, 2003.
- S. Sommer, C. B. Pudrith, C. J. Colvin, and P. M. Coussens, “Mycobacterium avium subspecies paratuberculosis suppresses expression of IL-12p40 and iNOS genes induced by signalling through CD40 in bovine monocyte-derived macrophages,” Veterinary Immunology and Immunopathology, vol. 128, no. 1–3, pp. 44–52, 2009.
- P. M. Coussens, “Model for immune responses to Mycobacterium avium subspecies paratuberculosis in cattle,” Infection and Immunity, vol. 72, no. 6, pp. 3089–3096, 2004.
- M. S. Khalifeh and J. R. Stabel, “Effects of gamma interferon, interleukin-10, and transforming growth factor β on the survival of Mycobacterium avium subsp. paratuberculosis in monocyte-derived macrophages from naturally infected cattle,” Infection and Immunity, vol. 72, no. 4, pp. 1974–1982, 2004.
- D. J. Weiss, O. A. Evanson, C. de Souza, and M. S. Abrahamsen, “A critical role of interleukin-10 in the response of bovine macrophages to infection by Mycobacterium avium subsp paratuberculosis,” American Journal of Veterinary Research, vol. 66, no. 4, pp. 721–726, 2005.
- D. E. de Almeida, C. J. Colvin, and P. M. Coussens, “Antigen-specific regulatory T cells in bovine paratuberculosis,” Veterinary Immunology and Immunopathology, vol. 125, no. 3-4, pp. 234–245, 2008.
- R. J. Chiodini, H. J. Van Kruiningen, and R. S. Merkal, “Ruminant paratuberculosis (Johne's disease): the current status and future prospects,” The Cornell Veterinarian, vol. 74, no. 3, pp. 218–262, 1984.
- D. J. Weiss, O. A. Evanson, A. Moritz, M. Q. Deng, and M. S. Abrahamsen, “Differential responses of bovine macrophages to Mycobacterium avium subsp. paratuberculosis and Mycobacterium avium subsp. avium,” Infection and Immunity, vol. 70, no. 10, pp. 5556–5561, 2002.
- H. K. Janagama, K. I. Jeong, V. Kapur, P. Coussens, and S. Sreevatsan, “Cytokine responses of bovine macrophages to diverse clinical Mycobacterium avium subspecies paratuberculosis strains,” BMC Microbiology, vol. 6, p. 10, 2006.
- D. J. Weiss, O. A. Evanson, M. Deng, and M. S. Abrahamsen, “Gene expression and antimicrobial activity of bovine macrophages in response to Mycobacterium avium subsp. paratuberculosis,” Veterinary Pathology, vol. 41, no. 4, pp. 326–337, 2004.
- J. T. Murphy, S. Sommer, E. A. Kabara et al., “Gene expression profiling of monocyte-derived macrophages following infection with Mycobacterium avium subspecies avium and Mycobacterium avium subspecies paratuberculosis,” Physiological Genomics, vol. 28, no. 1, pp. 67–75, 2006.
- P. M. Coussens, C. J. Colvin, G. J. M. Rosa, J. Perez Laspiur, and M. D. Elftman, “Evidence for a novel gene expression program in peripheral blood mononuclear cells from Mycobacterium avium subsp. paratuberculosis-infected cattle,” Infection and Immunity, vol. 71, no. 11, pp. 6487–6498, 2003.
- E. Kabara, C. C. Kloss, M. Wilson et al., “A large-scale study of differential gene expression in monocyte-derived macrophages infected with several strains of Mycobacterium avium subspecies paratuberculosis,” Briefings in Functional Genomics and Proteomics, vol. 9, no. 3, pp. 220–237, 2010.
- D. E. Machugh, M. Taraktsoglou, K. E. Killick et al., “Pan-genomic analysis of bovine monocyte-derived macrophage gene expression in response to in vitro infection with Mycobacterium avium subspecies paratuberculosis,” Veterinary Research, vol. 43, p. 25, 2012.
- N. Abendaño, I. A. Sevilla, J. M. Garrido, J. M. Prieto, R. A. Juste, and M. Alonso-Hearn, “Mycobacterium avium subspecies paratuberculosis isolates from sheep and goats show reduced persistence in bovine macrophages than cattle, bison, deer and wild boar strains regardless of genotype,” Veterinary Microbiology. In press.
- A. S. Motiwala, H. K. Janagama, M. L. Paustian et al., “Comparative transcriptional analysis of human macrophages exposed to animal and human isolates of Mycobacterium avium subspecies paratuberculosis with diverse genotypes,” Infection and Immunity, vol. 74, no. 11, pp. 6046–6056, 2006.
- S. Sibartie, P. Scully, J. Keohane et al., “Mycobacterium avium subsp. paratuberculosis (MAP) as a modifying factor in Crohn's disease,” Inflammatory Bowel Diseases, vol. 16, no. 2, pp. 296–304, 2010.
- N. Campos, F. Magro, A. R. Castro et al., “Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented pro-inflammatory responses to infection,” Immunobiology, vol. 216, no. 8, pp. 961–970, 2011.
- D. J. Weiss, O. A. Evanson, D. J. McClenahan, M. S. Abrahamsen, and B. K. Walcheck, “Regulation of expression of major histocompatibility antigens by bovine macrophages infected with Mycobacterium avium subsp. paratuberculosis or Mycobacterium avium subsp. avium,” Infection and Immunity, vol. 69, no. 2, pp. 1002–1008, 2001.
- I. Olsen, S. Tollefsen, C. Aagaard et al., “Isolation of Mycobacteriumavium subspecies paratuberculosis reactive CD4 T cells from intestinal biopsies of Crohn's disease patients,” PLoS ONE, vol. 22, p. 5641, 2009.